Synthesis and structure-activity relationship of novel pyridyl ethers for the nicotinic acetylcholine receptor

Bioorganic and Medicinal Chemistry Letters

Volumn 10, Issue 10, 2000, Pages 1063-1066

  Lee, Jung ^a   Davis, Coralie B ^a   Rivero, Ralph A ^a   Reitz, Allen B ^a   Shank, Richard P ^a  

^a RW Johnson Pharmaceutical Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 3 (4 CYANOPHENYL) 5 ((3 PYRROLIDINYL)OXY)PYRIDINE; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR AFFECTING AGENT; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; DRUG SYNTHESIS; STRUCTURE ACTIVITY RELATION;

BICYCLO COMPOUNDS, HETEROCYCLIC; ESTERS; INHIBITORY CONCENTRATION 50; LIGANDS; NICOTINE; NICOTINIC AGONISTS; PYRIDINES; PYRROLIDINES; RECEPTORS, NICOTINIC; STRUCTURE-ACTIVITY RELATIONSHIP;

OXY;

EID: 0034658029     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(00)00168-2     Document Type: Article

References (21)

1. (a) Spande, T. F.; Garraffo, H. M.; Edwards, M. W.; Yeh, H. J. C.; Pannel, L.; Daly, J. W. J. Am. Chem. Soc. 1992, 114, 3475.
2. (b) Li, T.; Qian, C.; Eckman, J.; Huang, D. F.; Shen, T. Y. Bioorg. Med. Chem. Lett. 1993, 3, 2759.
3. © Badio, B.; Daly, J. W. Mol. Pharmacol. 1994, 45, 563.
4. (d) Fisher, M.; Huangfu, D.; Shen, T. Y.; Guyenet, P. G. J. Pharmacol. Exp. Ther. 1994, 270, 702.
5. Bai D., Xu R., Zhu X. Drugs Future. 22:1997;1210.
6. (a) Bannon, A. W.; Decker, M. W.; Holladay, M. W.; Curzon, P.; Donnelly-Roberts, D.; Puttfarcken, P. S.; Bitner, R. S.; Diaz, A.; Dickenson, A. H.; Porsolt, R. D.; Williams, M.; Arneric, S. P. Science 1998, 279, 77.
7. (b) Holladay, M. W.; Wasicak, J. T.; Lin, N.-H.; He, Y.; Ryther, K. B.; Bannon, A. W.; Buckley, M. J.; Kim, D. J. B.; Decker, M. W.; Anderson, D. J.; Campbell, J. E.; Kuntzweiler, T. A.; Donnelly-Roberts, D. L.; Piattoni-Kaplan, M.; Briggs, C. A.; Williams, M.; Arneric, S. P. J. Med. Chem. 1998, 41, 407.
8. © Holladay, M. W.; Bai, H.; Li, Y.; Lin, N-H.; Daanen, J. F.; Ryther, K. B.; Wasicak, J. T.; Kincaid, J. F.; He, Y.; Hettinger, A.-M.; Huang, P.; Anderson, D. J.; Bannon, A. W.; Buckley, M. J.; Campbell, J. E.; Donnelly-Roberts, D. L.; Gunther, K. L.; Kim. D. J. B.; Kuntzweiler, T. A.; Sullivan, J. P.; Decker, M. W.; Arneric, S. P. Bioorg. Med. Chem. Lett. 1998, 8, 2797.
9. (d) Decker, M. W.; Bannon, A. W.; Buckley, M. J.; Kim, D. J. B.; Holladay, M. W.; Ryther, K. B.; Lin, N.-H.; Wasicak, J. T.; Williams, M.; Arneric, S. P. Eur. J. Pharmacol. 1998, 346, 23.
10. (e) Donnelly-Roberts, D. L.; Puttfarcken, P. S.; Kuntzweiler, T. A.; Briggs, C. A.; Anderson, D. J.; Campbell, J. E.; Piattoni-Kaplan, M.; Mckenna, D. G.; Wasicak, J. T.; Holladay, M. W.; Williams, M.; Arneric, S. P. J. Pharmacol. Exp. Ther. 1998, 285, 777.
11. (a) McDonald, I. A.; Vernier, J.-M.; Cosford, N.; Corey-Naeve, J. Curr. Pharmaceut. Des. 1996, 2, 357.
12. (b) Damaj, M. I.; Glassco, W.; Dukat, M.; May, E. L.; Glennon, R. A.; Martin, B. R. Drug Develop. Res. 1996, 38, 177.
13. © Glassco, W.; May, E. L.; Weaver, V.; Damaj, M. I.; Rosecrans, J.; Martin, B. R. Med. Chem. Res. 1994, 4, 474.
14. 3-Pyrrolidinol, (R)-(+)-pyrrolidinol, 3-hydroxypiperidine, and 1-methyl-3-pyrrolidinol were purchased from Aldrich. (S)-(-)-Pyrrolidinol was purchased from Synthon. 1-Ethyl, 1-ethyl-3-pyrrolidinols were purchased from TCI America. 1-(Diphenylmethyl)-3-hydroxyazetidine was purchased from the Maybridge Chemical Company.
15. Mitsunobu, O. Synthesis 1981, 1.
16. (a) Sonogashira, K.; Tohda, Y.; Hagihara, N. Tetrahedron Lett. 1975, 4467.
17. (b) Sakamoto, T.; Shiraiwa, M.; Kondo, Y.; Yamanaka, H. Synthesis 1983, 312.
18. (a) Stille, J. K.; Groh, B. L. J. Am. Chem. Soc. 1987, 109, 813.
19. (b) Stille, J. K. Angew. Chem., Int. Ed. Engl. 1986, 25, 508.
20. i of 4.44 and 2.67 nM, respectively. Lin, N-H.; Abreo, M. A.; Gunn, D. E.; Lebold, S. A.; Lee, E. L.; Wasicak, J. T.; Hettinger, A-H.; Daanen, J. F.; Garvey, D. S.; Campbell, J. E.; Sullivan, J. P.; Williams, M. W.; Arneric, S. P. Bioorg. Med. Chem. Lett. 1999, 9, 2747.
21. The binding assay was performed according to Pabreza, L. A.; Dhawan, S.; Kellar, K. J. Mol. Pharmacol. 1991, 39, 9.